Dolutegravir in late pregnancy: where to from here?
- PMID: 35905749
- DOI: 10.1016/S2352-3018(22)00193-X
Dolutegravir in late pregnancy: where to from here?
Conflict of interest statement
I declare no competing interests.
Comment on
-
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study.Lancet HIV. 2022 Aug;9(8):e534-e543. doi: 10.1016/S2352-3018(22)00173-4. Lancet HIV. 2022. PMID: 35905752 Clinical Trial.
Similar articles
-
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.N Engl J Med. 2018 Sep 6;379(10):979-981. doi: 10.1056/NEJMc1807653. Epub 2018 Jul 24. N Engl J Med. 2018. PMID: 30037297 Free PMC article. No abstract available.
-
The promise of paediatric dolutegravir.J Int AIDS Soc. 2021 Jan;24(1):e25660. doi: 10.1002/jia2.25660. J Int AIDS Soc. 2021. PMID: 33522081 Free PMC article. No abstract available.
-
Dolutegravir-induced hyperglycaemia in a patient living with HIV.J Antimicrob Chemother. 2018 Jan 1;73(1):258-260. doi: 10.1093/jac/dkx365. J Antimicrob Chemother. 2018. PMID: 29077869 No abstract available.
-
Pharmacokinetics and Safety of the Integrase Inhibitors Elvitegravir and Dolutegravir in Pregnant Women With HIV.Ann Pharmacother. 2019 Aug;53(8):833-844. doi: 10.1177/1060028019830788. Epub 2019 Feb 10. Ann Pharmacother. 2019. PMID: 30739498 Review.
-
Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection.Drugs. 2015 Apr;75(5):503-14. doi: 10.1007/s40265-015-0361-6. Drugs. 2015. PMID: 25698454 Review.
Cited by
-
Dolutegravir resistance in three pregnant and breastfeeding women in South Africa.South Afr J HIV Med. 2023 Nov 28;24(1):1531. doi: 10.4102/sajhivmed.v24i1.1531. eCollection 2023. South Afr J HIV Med. 2023. PMID: 38058846 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical